Harbor Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.13M | Buy |
87,886
+72
| +0.1% | +$1.75K | 0.09% | 285 |
|
|
2025
Q1 | $2.23M | Sell |
87,814
-26,685
| -23% | -$676K | 0.1% | 266 |
|
|
2024
Q4 | $3.04M | Buy |
114,499
+2,805
| +3% | +$74.4K | 0.13% | 215 |
|
|
2024
Q3 | $3.23M | Buy |
111,694
+535
| +0.5% | +$15.5K | 0.14% | 207 |
|
|
2024
Q2 | $3.11M | Buy |
111,159
+214
| +0.2% | +$5.99K | 0.24% | 120 |
|
|
2024
Q1 | $3.08M | Buy |
110,945
+13,462
| +14% | +$374K | 0.4% | 36 |
|
|
2023
Q4 | $2.81M | Sell |
97,483
-177
| -0.2% | -$5.1K | 0.54% | 32 |
|
|
2023
Q3 | $3.24M | Hold |
97,660
| – | – | 0.69% | 22 |
|
|
2023
Q2 | $3.58M | Hold |
97,660
| – | – | 0.72% | 19 |
|
|
2023
Q1 | $3.98M | Buy |
97,660
+96,031
| +5,895% | +$3.92M | 1.15% | 21 |
|
|
2022
Q4 | $83.5K | Sell |
1,629
-221
| -12% | -$11.3K | 0.08% | 101 |
|
|
2022
Q3 | $81K | Sell |
1,850
-1,250
| -40% | -$54.7K | 0.07% | 101 |
|
|
2022
Q2 | $163K | Sell |
3,100
-302
| -9% | -$15.9K | 0.12% | 93 |
|
|
2022
Q1 | $176K | Buy |
+3,402
| New | +$176K | 0.08% | 104 |
|